Agenus Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 50
- Published: May 2019
- Report Code: MLPH4419FSA
Agenus Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Agenus Inc (Agenus) is a clinical-stage immuno-oncology company that discovers, develops and commercializes a wide range of immunotherapeutics for the treatment of various types of cancers and infectious diseases. The company’s pipeline portfolio encompasses vaccines for glioblastoma, genital herpes, and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The company's technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. The company has collaborations with several pharmaceutical companies such as GSK, Incyte, and Merck; and universities such as UC San Francisco and UW Seattle. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.
Scope
Detailed information on Agenus Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Agenus Inc in the form of a SWOT analysis
An in-depth view of the business model of Agenus Inc including a breakdown and examination of key business segments
News about Agenus Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Agenus Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Agenus Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Agenus Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Northwest Biotherapeutics Inc
Green Cross Cell Corp
TVAX Biomedical Inc
Celldex Therapeutics Inc
Oxford BioMedica Plc
Idera Pharmaceuticals Inc
Dynavax Technologies Corp
Juvaris BioTherapeutics Inc
ImmunoCellular Therapeutics Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.